GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:ANTH
Delisted

Anthera Pharmaceuticals Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.000001
+0 (+0%)
At Close: May 27, 2022
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
2019-03-27 $0.0850 $0.100 $0.0850 $0.0990 15 015
2019-03-26 $0.0900 $0.0990 $0.0850 $0.0979 16 435
2019-03-25 $0.0979 $0.100 $0.0900 $0.0980 9 696
2019-03-22 $0.0930 $0.100 $0.0900 $0.0950 28 744
2019-03-21 $0.0991 $0.100 $0.0950 $0.0950 76 818
2019-03-20 $0.100 $0.100 $0.0900 $0.0995 5 801
2019-03-19 $0.0900 $0.100 $0.0900 $0.0990 18 154
2019-03-18 $0.0990 $0.0990 $0.0850 $0.0985 17 136
2019-03-15 $0.0800 $0.0994 $0.0800 $0.0955 17 122
2019-03-14 $0.0850 $0.0991 $0.0850 $0.0971 62 244
2019-03-13 $0.0850 $0.0991 $0.0850 $0.0991 12 470
2019-03-12 $0.0900 $0.0999 $0.0900 $0.0900 18 010
2019-03-11 $0.0990 $0.0990 $0.0800 $0.0990 25 003
2019-03-08 $0.0801 $0.0999 $0.0800 $0.0990 7 325
2019-03-07 $0.0998 $0.0998 $0.0800 $0.0980 7 849
2019-03-06 $0.0860 $0.0998 $0.0860 $0.0998 8 950
2019-03-05 $0.0900 $0.0925 $0.0830 $0.0925 15 134
2019-03-04 $0.0825 $0.0900 $0.0800 $0.0896 31 203
2019-03-01 $0.0800 $0.0900 $0.0800 $0.0898 38 018
2019-02-28 $0.0970 $0.0974 $0.0800 $0.0850 52 881
2019-02-27 $0.100 $0.100 $0.0790 $0.0950 90 243
2019-02-26 $0.0959 $0.100 $0.0790 $0.0945 19 773
2019-02-25 $0.0760 $0.0959 $0.0760 $0.0959 42 302
2019-02-22 $0.0650 $0.0969 $0.0650 $0.0948 13 347
2019-02-21 $0.0960 $0.0960 $0.0850 $0.0960 97 492
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Golden Star

Ticker Date Change Price
ITCI Apr 05 12.05% $68.44
AKR Apr 05 0.665% $16.53
SARK Mar 28 16.07% $26.88
ARCC Mar 25 1.04% $20.12
STT Mar 19 0.262% $72.62
GGB Mar 19 0.468% $4.27
CAG Mar 18 7.16% $28.22
JBI Mar 15 1.29% $14.72
MASI Mar 14 3.34% $132.20
CMC Mar 14 5.04% $53.19
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT